£54 million project benefits pre-clinical discovery CRO

Loughborough’s life sciences hub Charnwood Campus in the UK has recommissioned its synthetic and chemistry research facility to cater to the needs of pre-clinical discovery contract research organisation (CRO) Charnwood Molecular. It will cost £54 million.

The new laboratories will provide capacity for future growth and expansion of Charnwood Molecular’s medicinal chemistry and process research teams, as well as facilitate the addition of drug discovery service lines.

Charnwood Campus Commercial Director Gosia Khrais said: “We are lucky to have a forward-thinking and business- and community-orientated council, as well as an open-minded and ambitious LLEP. Over the years, we have received a lot of positive feedback from local businesses and Loughborough residents. We are very humbled and grateful for that support, and we will continue to work tirelessly to facilitate job creation, accelerate economic growth and play our part in the Covid recovery effort.”

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free